Financial Times FT.com

Supersized Problems

By Andrew Jack

Published: July 19 2008 03:00 | Last updated: July 19 2008 03:00

The government's medicines advisory agency this month recommended a new medicine that provides fresh hope in the fight against obesity.

Rimonabant, known by the brand name Acomplia, joins orlistat (Xenical) and sibutramine (Reductil) in the range of weight-loss drugs available from doctors on prescription.

You have viewed your allowance of free articles. If you wish to view more, click the button below.

Read this